IDEXX Laboratories, Inc.
DE ˙ XTRA ˙ US45168D1046
490,30 € ↑19,90 (4,23%)
2026-06-04
DEL PRIS
SecurityDE:IX1 / IDEXX Laboratories, Inc.
InstitutionAlgert Global Llc
Latest Disclosed Ownership9,945 shares
Latest Disclosed Value $ 5,588
Algert Global Llc reports 10.25% increase in ownership of IX1 / IDEXX Laboratories, Inc.

On May 14, 2026 - Algert Global Llc filed a 13F-HR form disclosing ownership of 9,945 shares of IDEXX Laboratories, Inc. (DE:IX1) valued at $4,853,160 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 9,020 shares of IDEXX Laboratories, Inc.. This represents a change in shares of 10.25% during the quarter. The current value of the position is $4,876,034 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F IDEXX LABS COM 45168D104 9,945 925 10.25 6 -16.67 0.0841
2026-02-17 2025-12-31 13F IDEXX LABS COM 45168D104 9,020 8,333 1,212.95 6 0.0951
2025-11-14 2025-09-30 13F IDEXX LABS COM 45168D104 687 687 0 0.0073
2025-08-14 2025-06-30 13F IDEXX LABS COM 45168D104 0 -11,063 -100.00 0 -100.00
2025-05-13 2025-03-31 13F IDEXX LABS COM 45168D104 11,063 950 9.39 5 0.00 0.1149
2025-02-14 2024-12-31 13F IDEXX LABS COM 45168D104 10,113 942 10.27 4 0.00 0.0984
2024-11-12 2024-09-30 13F IDEXX LABS COM 45168D104 9,171 8,462 1,193.51 5 0.1246
2024-08-15 2024-06-30 13F IDEXX LABS COM 45168D104 709 292 70.02 0 0.0115
2024-05-15 2024-03-31 13F IDEXX LABS COM 45168D104 417 -870 -67.60 0 0.0088
2024-02-14 2023-12-31 13F IDEXX LABS COM 45168D104 1,287 632 96.49 1 0.0288
2023-11-13 2023-09-30 13F IDEXX LABS COM 45168D104 655 -1,784 -73.14 0 -100.00 0.0134
2023-08-14 2023-06-30 13F IDEXX LABS COM 45168D104 2,439 140 6.09 1 0.00 0.0533
2023-05-12 2023-03-31 13F IDEXX LABS COM 45168D104 2,299 -1,136 -33.07 1 0.00 0.0543
2023-02-14 2022-12-31 13F IDEXX LABS COM 45168D104 3,435 145 4.41 1 -99.91 0.0776
2022-11-15 2022-09-30 13F IDEXX LABS COM 45168D104 3,290 34 1.04 1,072 -6.13 0.0648
2022-08-15 2022-06-30 13F IDEXX LABS COM 45168D104 3,256 543 20.01 1,142 -23.05 0.0859
2022-05-16 2022-03-31 13F IDEXX LABS COM 45168D104 2,713 -394 -12.68 1,484 -27.47 0.0971
2022-02-14 2021-12-31 13F IDEXX LABS COM 45168D104 3,107 75 2.47 2,046 8.48 0.2555
2021-11-15 2021-09-30 13F IDEXX LABS COM 45168D104 3,032 169 5.90 1,886 4.31 0.2510
2021-08-13 2021-06-30 13F IDEXX LABS COM 45168D104 2,863 -317 -9.97 1,808 16.20 0.6087
2021-05-14 2021-03-31 13F IDEXX LABS COM 45168D104 3,180 -1,860 -36.90 1,556 -38.23 0.4977
2021-02-12 2020-12-31 13F IDEXX LABS COM 45168D104 5,040 -406 -7.46 2,519 17.66 0.7184
2020-11-16 2020-09-30 13F IDEXX LABS COM 45168D104 5,446 -394 -6.75 2,141 11.05 0.6798
2020-08-12 2020-06-30 13F IDEXX LABS COM 45168D104 5,840 347 6.32 1,928 44.85 0.6547
2020-05-13 2020-03-31 13F IDEXX LABS COM 45168D104 5,493 -3,941 -41.77 1,331 -45.98 0.5612
2020-02-18 2019-12-31 13F IDEXX LABS COM 45168D104 9,434 0 0.00 2,464 -3.94 0.7359
2019-11-13 2019-09-30 13F IDEXX LABS COM 45168D104 9,434 0 0.00 2,565 -1.23 0.9563
2019-08-14 2019-06-30 13F IDEXX LABS COM 45168D104 9,434 4,776 102.53 2,597 149.23 0.9598
2019-05-01 2019-03-31 13F IDEXX LABS COM 45168D104 4,658 -10,125 -68.49 1,042 -62.11 0.5954
2019-02-01 2018-12-31 13F IDEXX LABS COM 45168D104 14,783 -495 -3.24 2,750 -27.90 0.7667
2018-11-14 2018-09-30 13F IDEXX LABS COM 45168D104 15,278 -279 -1.79 3,814 12.51 0.8225
2018-08-01 2018-06-30 13F IDEXX LABS COM 45168D104 15,557 13,271 580.53 3,390 673.97 0.7039
2018-05-02 2018-03-31 13F IDEXX LABS COM 45168D104 2,286 -91 -3.83 438 17.74 0.0849
2018-02-01 2017-12-31 13F IDEXX LABS COM 45168D104 2,377 -598 -20.10 372 -19.65 0.0878
2017-11-16 2017-09-30 13F IDEXX LABS COM 45168D104 2,975 -10,935 -78.61 463 -79.38 0.1059
2017-07-31 2017-06-30 13F IDEXX LABS COM 45168D104 13,910 13,910 2,245 0.6303
2017-01-25 2016-12-31 13F IDEXX LABS COM 45168D104 0 -24,846 -100.00 0 -100.00
2016-10-11 2016-09-30 13F IDEXX LABS COM 45168D104 24,846 24,846 2,801 0.8100
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.